Immediate Impact
25 standout
Citing Papers
Enhancing Therapy Adherence: Impact on Clinical Outcomes, Healthcare Costs, and Patient Quality of Life
2025 Standout
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
Works of Helen Moon being referenced
Enfortumab vedotin (EV) alone or in combination with pembrolizumab (P) in previously untreated cisplatin-ineligible patients with locally advanced or metastatic urothelial cancer (la/mUC): Subgroup analyses of confirmed objective response rate (cORR) from EV-103 cohort K.
2023
A pharmacist based intervention to improve the care of patients with CKD: a pragmatic, randomized, controlled trial
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Helen Moon | 74 | 61 | 43 | 25 | 164 | |
| Do-Kyong Kim | 54 | 133 | 66 | 24 | 256 | |
| Mudassar Hussain | 26 | 39 | 43 | 37 | 167 | |
| Sharon Peacock Hinton | 41 | 142 | 47 | 24 | 272 | |
| Jong Soo Lee | 58 | 76 | 42 | 29 | 287 | |
| Anna Rachelle Mislang | 30 | 119 | 56 | 25 | 264 | |
| Sailesh Lodha | 95 | 28 | 24 | 24 | 268 | |
| Afshan Zahedi | 65 | 35 | 10 | 16 | 294 | |
| Fabio Robusto | 65 | 51 | 17 | 22 | 232 | |
| C Pernot | 31 | 20 | 13 | 28 | 148 | |
| Masayuki Nakashima | 141 | 134 | 104 | 30 | 290 |
All Works
Loading papers...